Under the centralized procurement, a large number of medical representatives are facing elimination!

[Pharmaceutical Network Market Analysis] Recently, the news that a maternal and child health care hospital has taken many measures to strengthen the management of medical representatives has made the industry of medical representatives once again become the focus of the industr.
According to related reports, in order to curb the "rebate" in the medical field and promote the construction of a clean hospital, a city's maternal and child health care hospital passed the "Administrative Measures for the Reception of Medical Representatives" and the "Medical Representative Appointment Reception Day System" and immediately issued it to the various departments of the hospital to request receptio.
Departments should conduct reception in accordance with the requirements of "three certainties and one existence", that is, specified time, specified location, specified personnel, and record.
Up to now, 2 violations have been found, and the corresponding measures are: suspend the drugs of enterprises that violate the regulations of the hospital's medical representatives, and include them in the hospital's drug procurement blacklist, and deduct the performance penalties of the month for the relevant doctors who violate the regulations on receptio.
, and conducted an interview with the director of the department, and circulated and criticized the whole hospita.
It can be seen from this case that the costs faced by medical representatives in violation of regulations are not smal.
The hospital also stated that the next step will be to hold a "medical representative reception symposium" on a regular and continuous basis to create a clean buying and selling environment for the hospita.
In recent years, in order to build a "clean and healthy" medical environment and reduce the burden of patients' medical expenses, the state has frequently made "heavy blows" on the purchase and sale of medicines and anti-corruptio.
focus on strict contro.
In August 2020, the National Medical Insurance Bureau officially launched the construction of a pharmaceutical price and credit evaluation system for recruitment and procurement, including pharmaceutical commercial bribery and other acts on the list of untrustworthy matters, and effectively restraining pharmaceutical companies’ sales behavior through measures such as keeping promises, credit rating, and graded disposa.
.On December 1, 2020, the filing system for medical representatives was officially implemented, and then various provinces, cities or hospitals formulated corresponding regulations for medical representative.
A large number of medical representatives with insufficient academic promotion ability are facing elimination or transformatio.
In August 2021, the National Health and Medical Commission issued the "Notice on Printing and Distributing the National Action Plan for the Incorruptible Practice of Medical Institutions and Their Staff (2021-2024)", which clearly required the improvement of the management system of medical representatives visiting medical staff in the hospital, and the violation of regulation.
Persons who appear in the clinic and have nothing to do with the diagnosis and treatment activities should be expelled in time, the verified delivery of kickbacks should be reported in a timely manner, and the medical personnel who received kickbacks should be severely punished according to the amount, and those suspected of committing crimes should be transferred to judicial organ.
.
.
.
. Under the strict control at all levels, coupled with the normalization of centralized procurement, which forced the price of medicines to be reduced, the winning bidders exchanged price for quantity, and continuously disbanded the sales forc.
The life of medical representatives has become more and more difficul.
So, what is the future of the industry? The industry believes that although medical representatives are facing stricter supervision, they are not no longer neede.
For example, medical representatives are still needed in clinical practic.
Therefore, medical representatives should return to their own values, play the role of academic promotion of drugs, help doctors rationally use drugs, and constantly learn to improve their professional ability and professionalis.
For medical representatives seeking transformation, there are many ways ou.
For example, you can consider out-of-hospital busines.
In recent years, it is difficult for pharmaceutical hospitals to enter the hospita.
Many manufacturers aim at DTP pharmacies, or do out-of-hospital pharmacies not far from the hospita.
The industry believes that the out-of-hospital prescription market is huge, or it is an optio.
However, it should be reminded that the transformation of any industry is not easy, and not all medical representatives can successfully transform, and they need to make judgments based on their own abilitie.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyon.